• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Treatment of hypertension in obese patients].

作者信息

Comte-Perret Sophie, Giusti Vittorio, Wuerzner Grégoire

机构信息

Service d'endocrinologie, diabétologie et métabolisme, CHUV, 1011 Lausanne.

出版信息

Rev Med Suisse. 2013 Sep 11;9(397):1622, 1624-6.

PMID:24073473
Abstract

Prevalence of obesity and hypertension has increased these last decades. Around 60 to 70% of the incidence of hypertension is related to obesity. The relationship between obesity and hypertension is now well established. The sympathetic nervous system and the renin-angiotensin-aldosterone (RAA) system are activated in obese patients, mostly by insulin, and predispose the kidney to reabsorb sodium and water. In obese patients with hypertension, it is recommended to target a blood pressure < 140/90 mmHg. Lifestyle changes (weight loss, physical activity, low-salt diets) are useful to decrease blood pressure but are difficult to maintain in the long-term. When drugs are necessary, drugs that are metabolically neutral should be used, and often need to be combined to other drug classes in order to achieve blood pressure target.

摘要

相似文献

1
[Treatment of hypertension in obese patients].
Rev Med Suisse. 2013 Sep 11;9(397):1622, 1624-6.
2
Mechanisms of obesity-induced hypertension.肥胖导致高血压的机制。
Hypertens Res. 2010 May;33(5):386-93. doi: 10.1038/hr.2010.9.
3
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.肥胖与高血压:机制、心肾后果及治疗方法
Med Clin North Am. 2009 May;93(3):733-51. doi: 10.1016/j.mcna.2009.02.010.
4
Mechanisms of hypertension in obesity.肥胖症中高血压的发病机制。
Kidney Int Suppl. 1987 Oct;22:S254-8.
5
Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.肥胖相关性高血压:流行病学、病理生理学和临床管理。
Am J Hypertens. 2010 Nov;23(11):1170-8. doi: 10.1038/ajh.2010.172. Epub 2010 Aug 12.
6
The Role of Aldosterone in Obesity-Related Hypertension.醛固酮在肥胖相关高血压中的作用。
Am J Hypertens. 2016 Apr;29(4):415-23. doi: 10.1093/ajh/hpw003. Epub 2016 Feb 28.
7
Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.欧洲肥胖研究学会和欧洲高血压学会联合声明:肥胖与难治性动脉高血压。
J Hypertens. 2012 Jun;30(6):1047-55. doi: 10.1097/HJH.0b013e3283537347.
8
Sleep apnea, aldosterone, and resistant hypertension.睡眠呼吸暂停、醛固酮与顽固性高血压。
Prog Cardiovasc Dis. 2009 Mar-Apr;51(5):371-80. doi: 10.1016/j.pcad.2008.02.004.
9
[Obesity-related hypertension].[肥胖相关性高血压]
Ned Tijdschr Geneeskd. 2011;154:A1945.
10
The effect of nutrition on blood pressure.营养对血压的影响。
Annu Rev Nutr. 2010 Aug 21;30:365-401. doi: 10.1146/annurev-nutr-010510-103954.